Infectious Disease Clinics of North America, volume 30, issue 2, pages 523-537

Aminoglycoside Resistance

Doi Yohei 1
Wachino Jun-ichi 2
Arakawa Yoshichika 2
1
 
Division of Infectious Diseases, University of Pittsburgh School of Medicine, S829 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA.
2
 
Department of Bacteriology, Nagoya University School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya, Aichi 466-8550, Japan
Publication typeJournal Article
Publication date2016-06-01
Quartile SCImago
Q1
Quartile WOS
Q2
Impact factor4.4
ISSN08915520, 15579824
Microbiology (medical)
Infectious Diseases
Abstract
Aminoglycoside-producing Actinobacteria are known to protect themselves from their own aminoglycoside metabolites by producing 16S ribosomal RNA methyltransferase (16S-RMTase), which prevents them from binding to the 16S rRNA targets. Ten acquired 16S-RMTases have been reported from gram-negative pathogens. Most of them posttranscriptionally methylate residue G1405 of 16S rRNA resulting in high-level resistance to gentamicin, tobramycin, amikacin, and plazomicin. Strains that produce 16S-RMTase are frequently multidrug-resistant or even extensively drug-resistant. Although the direct clinical impact of high-level aminoglycoside resistance resulting from production of 16S-RMTase is yet to be determined, ongoing spread of this mechanism will further limit treatment options for multidrug-resistant and extensively drug-resistant gram-negative infections.

Citations by journals

2
4
6
8
10
Antibiotics
Antibiotics, 10, 4.31%
Antibiotics
10 publications, 4.31%
Frontiers in Microbiology
Frontiers in Microbiology, 9, 3.88%
Frontiers in Microbiology
9 publications, 3.88%
Journal of Antimicrobial Chemotherapy
Journal of Antimicrobial Chemotherapy, 9, 3.88%
Journal of Antimicrobial Chemotherapy
9 publications, 3.88%
Microbial Drug Resistance
Microbial Drug Resistance, 8, 3.45%
Microbial Drug Resistance
8 publications, 3.45%
International Journal of Antimicrobial Agents
International Journal of Antimicrobial Agents, 8, 3.45%
International Journal of Antimicrobial Agents
8 publications, 3.45%
Journal of Global Antimicrobial Resistance
Journal of Global Antimicrobial Resistance, 8, 3.45%
Journal of Global Antimicrobial Resistance
8 publications, 3.45%
Antimicrobial Agents and Chemotherapy
Antimicrobial Agents and Chemotherapy, 8, 3.45%
Antimicrobial Agents and Chemotherapy
8 publications, 3.45%
Diagnostic Microbiology and Infectious Disease
Diagnostic Microbiology and Infectious Disease, 7, 3.02%
Diagnostic Microbiology and Infectious Disease
7 publications, 3.02%
ACS Infectious Diseases
ACS Infectious Diseases, 6, 2.59%
ACS Infectious Diseases
6 publications, 2.59%
International Journal of Molecular Sciences
International Journal of Molecular Sciences, 6, 2.59%
International Journal of Molecular Sciences
6 publications, 2.59%
Journal of Medical Microbiology
Journal of Medical Microbiology, 5, 2.16%
Journal of Medical Microbiology
5 publications, 2.16%
Microorganisms
Microorganisms, 5, 2.16%
Microorganisms
5 publications, 2.16%
Microbiology spectrum
Microbiology spectrum, 4, 1.72%
Microbiology spectrum
4 publications, 1.72%
European Journal of Clinical Microbiology and Infectious Diseases
European Journal of Clinical Microbiology and Infectious Diseases, 3, 1.29%
European Journal of Clinical Microbiology and Infectious Diseases
3 publications, 1.29%
Journal of Clinical Microbiology
Journal of Clinical Microbiology, 3, 1.29%
Journal of Clinical Microbiology
3 publications, 1.29%
Clinical Microbiology Reviews
Clinical Microbiology Reviews, 3, 1.29%
Clinical Microbiology Reviews
3 publications, 1.29%
Future Microbiology
Future Microbiology, 2, 0.86%
Future Microbiology
2 publications, 0.86%
BMC Microbiology
BMC Microbiology, 2, 0.86%
BMC Microbiology
2 publications, 0.86%
Frontiers in Public Health
Frontiers in Public Health, 2, 0.86%
Frontiers in Public Health
2 publications, 0.86%
Frontiers in Cellular and Infection Microbiology
Frontiers in Cellular and Infection Microbiology, 2, 0.86%
Frontiers in Cellular and Infection Microbiology
2 publications, 0.86%
Frontiers in Pharmacology
Frontiers in Pharmacology, 2, 0.86%
Frontiers in Pharmacology
2 publications, 0.86%
Current Microbiology
Current Microbiology, 2, 0.86%
Current Microbiology
2 publications, 0.86%
Journal of Infection and Chemotherapy
Journal of Infection and Chemotherapy, 2, 0.86%
Journal of Infection and Chemotherapy
2 publications, 0.86%
International Journal of Infectious Diseases
International Journal of Infectious Diseases, 2, 0.86%
International Journal of Infectious Diseases
2 publications, 0.86%
Indian Journal of Medical Microbiology
Indian Journal of Medical Microbiology, 2, 0.86%
Indian Journal of Medical Microbiology
2 publications, 0.86%
Microbial Pathogenesis
Microbial Pathogenesis, 2, 0.86%
Microbial Pathogenesis
2 publications, 0.86%
Clinical Infectious Diseases
Clinical Infectious Diseases, 2, 0.86%
Clinical Infectious Diseases
2 publications, 0.86%
Journal of the American Chemical Society
Journal of the American Chemical Society, 2, 0.86%
Journal of the American Chemical Society
2 publications, 0.86%
mSphere
mSphere, 2, 0.86%
mSphere
2 publications, 0.86%
2
4
6
8
10

Citations by publishers

5
10
15
20
25
30
35
40
45
Elsevier
Elsevier, 45, 19.4%
Elsevier
45 publications, 19.4%
Springer Nature
Springer Nature, 28, 12.07%
Springer Nature
28 publications, 12.07%
Multidisciplinary Digital Publishing Institute (MDPI)
Multidisciplinary Digital Publishing Institute (MDPI), 28, 12.07%
Multidisciplinary Digital Publishing Institute (MDPI)
28 publications, 12.07%
American Society for Microbiology
American Society for Microbiology, 23, 9.91%
American Society for Microbiology
23 publications, 9.91%
Frontiers Media S.A.
Frontiers Media S.A., 15, 6.47%
Frontiers Media S.A.
15 publications, 6.47%
Oxford University Press
Oxford University Press, 14, 6.03%
Oxford University Press
14 publications, 6.03%
Wiley
Wiley, 11, 4.74%
Wiley
11 publications, 4.74%
American Chemical Society (ACS)
American Chemical Society (ACS), 10, 4.31%
American Chemical Society (ACS)
10 publications, 4.31%
Mary Ann Liebert
Mary Ann Liebert, 8, 3.45%
Mary Ann Liebert
8 publications, 3.45%
Microbiology Society
Microbiology Society, 6, 2.59%
Microbiology Society
6 publications, 2.59%
Wolters Kluwer Health
Wolters Kluwer Health, 4, 1.72%
Wolters Kluwer Health
4 publications, 1.72%
Bentham Science
Bentham Science, 2, 0.86%
Bentham Science
2 publications, 0.86%
Future Medicine
Future Medicine, 2, 0.86%
Future Medicine
2 publications, 0.86%
Taylor & Francis
Taylor & Francis, 2, 0.86%
Taylor & Francis
2 publications, 0.86%
Pleiades Publishing
Pleiades Publishing, 1, 0.43%
Pleiades Publishing
1 publication, 0.43%
Sociedade Brasileira de Medicina Tropical, 1, 0.43%
Sociedade Brasileira de Medicina Tropical
1 publication, 0.43%
Centers for Disease Control and Prevention (CDC)
Centers for Disease Control and Prevention (CDC), 1, 0.43%
Centers for Disease Control and Prevention (CDC)
1 publication, 0.43%
European Respiratory Society (ERS)
European Respiratory Society (ERS), 1, 0.43%
European Respiratory Society (ERS)
1 publication, 0.43%
PeerJ
PeerJ, 1, 0.43%
PeerJ
1 publication, 0.43%
The Royal Society
The Royal Society, 1, 0.43%
The Royal Society
1 publication, 0.43%
SAGE
SAGE, 1, 0.43%
SAGE
1 publication, 0.43%
Public Library of Science (PLoS)
Public Library of Science (PLoS), 1, 0.43%
Public Library of Science (PLoS)
1 publication, 0.43%
American Society for Biochemistry and Molecular Biology
American Society for Biochemistry and Molecular Biology, 1, 0.43%
American Society for Biochemistry and Molecular Biology
1 publication, 0.43%
Walter de Gruyter
Walter de Gruyter, 1, 0.43%
Walter de Gruyter
1 publication, 0.43%
Royal Society of Chemistry (RSC)
Royal Society of Chemistry (RSC), 1, 0.43%
Royal Society of Chemistry (RSC)
1 publication, 0.43%
Dove Medical Press
Dove Medical Press, 1, 0.43%
Dove Medical Press
1 publication, 0.43%
Journal of Pure and Applied Microbiology, 1, 0.43%
Journal of Pure and Applied Microbiology
1 publication, 0.43%
Hindawi Limited
Hindawi Limited, 1, 0.43%
Hindawi Limited
1 publication, 0.43%
Maruzen Co., Ltd/Maruzen Kabushikikaisha, 1, 0.43%
Maruzen Co., Ltd/Maruzen Kabushikikaisha
1 publication, 0.43%
5
10
15
20
25
30
35
40
45
  • We do not take into account publications that without a DOI.
  • Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
  • Statistics recalculated weekly.
Metrics
Share
Cite this
GOST |
Cite this
GOST Copy
Doi Y., Wachino J., Arakawa Y. Aminoglycoside Resistance // Infectious Disease Clinics of North America. 2016. Vol. 30. No. 2. pp. 523-537.
GOST all authors (up to 50) Copy
Doi Y., Wachino J., Arakawa Y. Aminoglycoside Resistance // Infectious Disease Clinics of North America. 2016. Vol. 30. No. 2. pp. 523-537.
RIS |
Cite this
RIS Copy
TY - JOUR
DO - 10.1016/j.idc.2016.02.011
UR - https://doi.org/10.1016%2Fj.idc.2016.02.011
TI - Aminoglycoside Resistance
T2 - Infectious Disease Clinics of North America
AU - Doi, Yohei
AU - Wachino, Jun-ichi
AU - Arakawa, Yoshichika
PY - 2016
DA - 2016/06/01 00:00:00
PB - Elsevier
SP - 523-537
IS - 2
VL - 30
PMID - 27208771
SN - 0891-5520
SN - 1557-9824
ER -
BibTex |
Cite this
BibTex Copy
@article{2016_Doi,
author = {Yohei Doi and Jun-ichi Wachino and Yoshichika Arakawa},
title = {Aminoglycoside Resistance},
journal = {Infectious Disease Clinics of North America},
year = {2016},
volume = {30},
publisher = {Elsevier},
month = {jun},
url = {https://doi.org/10.1016%2Fj.idc.2016.02.011},
number = {2},
pages = {523--537},
doi = {10.1016/j.idc.2016.02.011}
}
MLA
Cite this
MLA Copy
Doi, Yohei, et al. “Aminoglycoside Resistance.” Infectious Disease Clinics of North America, vol. 30, no. 2, Jun. 2016, pp. 523-537. https://doi.org/10.1016%2Fj.idc.2016.02.011.
Found error?